Publications by authors named "Yunhee Ham"

Claim this Profile
K
KML001, a telomere-targeting drug, sensitizes glioblastoma cells to temozolomide chemotherapy and radiotherapy through DNA damage and apoptosis.
Seon Rang Woo, Yunhee Ham, Wonyoung Kang, Heekyoung Yang, Sujong Kim

Biomed Res Intยท June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis